Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Prevalence of infection with HIV, hepatitis B and C viruses, in four high risk groups in Eritrea.

Clin Diagn Virol. 1998 Jan;9(1):29-35. Unique Identifier : AIDSLINE MED/98223949
Ghebrekidan H; Cox S; Wahren B; Grandien M; Department of Virology, Swedish Institute for Infectious Disease; Control, Karolinska Institute, Stockholm, Sweden.


Abstract: BACKGROUND: Little is known about the prevalence of infections in different population groups in Africa, and about the influence of living conditions on the spread of infections. This study is the first of its kind in the state of Eritrea and is expected to serve as an evaluation of the situation in the country. OBJECTIVE: A serosurvey for human immunodeficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) was carried out during the summer of 1995 in Massawa, a small sea port in Eritrea (East Africa) in four groups considered to be at risk for these infections. STUDY DESIGN: The study subjects were former Guerrilla Fighters, Female Sex Workers, Truck Drivers, and Port Workers. Participants from a tribe called Rashaida were believed to be at low risk, and thus served as a control. RESULTS: The Female Sex Workers had the highest incidence of HIV-1 infection, 29%, compared to 10% for Port Workers, and 3% for Guerrilla Fighters. On the other hand presence of HBsAg, indicating a high prevalence of hepatitis B carrier status, was highest in the Guerrilla Fighters, followed by the Rashaidas, and lowest in the Female Sex Workers. The Female Sex Workers were further tested for antibodies against HBV and the results revealed that 53% of them, 5%, had antibodies against HBcoreAg. Excluding the possibility of an acute infection at sampling time, three of them became HBsAg carriers. Surprisingly, our group of Truck Drivers did not show HIV-1 infection, and no HIV-2 infections were seen in the whole cohort. CONCLUSION: The study shows that the described groups have different prevalences of infection with HIV, hepatitis B and C which can partly be explained by their living conditions.
Keywords: *Acquired Immunodeficiency Syndrome/COMPLICATIONS *Acquired Immunodeficiency Syndrome/IMMUNOLOGY *Acquired Immunodeficiency Syndrome/VIROLOGY *Hepatitis B, Chronic/COMPLICATIONS *Hepatitis B, Chronic/IMMUNOLOGY *Hepatitis B, Chronic/VIROLOGY *Hepatitis C/COMPLICATIONS *Hepatitis C/IMMUNOLOGY *Hepatitis C/VIROLOGY

KWDacquiredimmunodeficiencysyndrome/complicationsKWDacquiredimmunodeficiencysyndrome/immunologyKWDacquiredimmunodeficiencysyndrome/virologyKWDhepatitisb,chronic/complicationsKWDhepatitisb,chronic/immunologyKWDhepatitisb,chronic/virologyKWDhepatitisc/complicationsKWDhepatitisc/immunologyKWDhepatitisc/virology
980730
M9871338


Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .